Masimo | MASI - Net Income

Stock Price
175.26
Daily Change
-0.09 -0.05%
Monthly
25.01%
Yearly
-7.99%
Q1 Forecast
169.67

Masimo reported $-100.4M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Accuray USD 2.54M 6.49M Dec/2024
Align Technology USD 135.76M 79.01M Dec/2025
AngioDynamics USD -4.41M 6.33M Feb/2025
Artivion USD -2.29M 167K Sep/2024
AtriCure USD 1.76M 2.02M Dec/2025
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
General Electric Aerospace USD 2.54B 384M Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.14B 231M Dec/2025
Orthofix International USD -126M 98.61M Dec/2024
Owens Minor USD -24.98M 271.13M Mar/2025
ResMed USD 392.59M 44.06M Dec/2025
Steris USD 192.9M 1000K Dec/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -408.89M 531.47M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025